Namaste Technologies Provides Corporate Update

TORONTO, Sept. 28, 2020 /CNW/ – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), a leading online platform for cannabis products, accessories, and responsible education, is pleased to provide a corporate update with regards to a change in management and the settlement of an outstanding claim to the benefit of Company shareholders. Namaste to AppointContinue reading “Namaste Technologies Provides Corporate Update”

Tetra Bio-Pharma Announces Plenitude Clinical Trial is Initiated

OTTAWA-  Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has initiated the in-life phase of the clinical trial operations now that the investigational QIXLEEF™ drug has been shipped by Aphria Inc. The Plenitude© trial is designed to prove the efficacy and safety of QIXLEEF™Continue reading “Tetra Bio-Pharma Announces Plenitude Clinical Trial is Initiated”

Aleafia Health Announces Second Quarter 2020 Results

“Our significant increase in medical cannabis sales and patient growth, coupled with much needed Cannabis 2.0 formats and dried flower products will see us continue to capture market in both the medical and adult-use markets.” CEO Geoffrey Benic Highlights $57.0M cash, cash equivalents and freely tradeable marketable securities $3.0 million positive adjusted EBITDA 44% increaseContinue reading “Aleafia Health Announces Second Quarter 2020 Results”

CB2 Insights Announces Amendments to Promissory Note held by Merida Capital Partners

“CB2 is one of those rare companies that has grown into a profitable enterprise in the cannabis landscape.” CB2 Insights (CSE: CBII; OTCQB: CBIIF), announces that it has amended the terms of its issued and outstanding promissory note held by Merida Capital Partners (“Merida”), which is designed to help the Company achieve its long termContinue reading “CB2 Insights Announces Amendments to Promissory Note held by Merida Capital Partners”